Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | STLNWStarling Oncology, Inc.FY2025 · Dec |
|---|---|
| Revenue | $502.73M |
| Revenue, yoy | +27.8% |
| Net income | $60.61M |
| Net income, yoy | +6.3% |
| Net margin | -12.1% |
| Free cash flow | $27.79M |
| FCF margin | -5.5% |
| EPS, diluted | $0.54 |
Add another company.